# 465489/2014-1) and the National Council for Scientific and Technological Development (CNPq;#301777/2012-8)
While the menu was designed with GLP-1 users in mind, these smoothies can also work for people who arent taking GLP-1 medications but are looking for healthier options
As patents expire, this creates opportunities for various companies to manufacture cheaper biosimilars, resulting in intense competition, thus significantly lowering the cost of treatment
To further investigate whether the TXNIP/NLRP3 signaling pathway mediates the renoprotective effects of semaglutide and adenosine in obese mice, this study builds upon prior research by designing a new set of experiments
Inagaki N, Takeuchi M, Oura T, Imaoka T, Seino Y (2022) Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial